Biointron

Biointron

生物技术研究

Zhoupu Town, Pudong New District,Shanghai 5,331 位关注者

Recombinant Antibody Expression, Delivery in 2 weeks (From Gene Sequence to Purified Antibody)

关于我们

About Biointron: Founded in 2012 Certified to ISO 9001:2015 High-technology Enterprises CRO supplier for antibody discovery and expression Biointron, founded in 2012, is an award-winning international high-tech enterprise based in Shanghai. We specialize in antibody expression, discovery, and optimization. Our mission is to accelerate the antibody discovery process to provide one-stop antibody discovery services. With fully automated production processes adhering to international standards, we've served 1,500+ pharmaceutical companies across 20 countries. Our expertise includes VHH production, hybridoma sequencing, antibody humanization, affinity maturation, and single B cell screening. Biointron has global commercialization reauthorization for ECACC's CHO-K1 cell line and meets international multicenter requirements, which has also been filed with the U.S. FDA's DMF and several partners’ projects have entered the international multicenter clinical stage. For more information, please visit our official website at www.biointron.com or contact us at info@biointron.com

所属行业
生物技术研究
规模
501-1,000 人
总部
Zhoupu Town, Pudong New District,Shanghai
类型
私人持股
创立
2012
领域
cytokines、recombinant proteins、get purified antibody with 2 weeks from Gene synthesis、100 L fermentor、Antibody Discovery、Stable Cell Line和Antibody Humanization

地点

  • 主要

    No. 1-9 Lane 99, Shenmei Road

    CN,Shanghai,Zhoupu Town, Pudong New District,201318

    获取路线
  • 20 Bridge St

    US,New Jersey,Metuchen,08840

    获取路线

Biointron员工

动态

相似主页

融资

Biointron 共 2 轮

上一轮

B 轮

US$72,564,728.00

Crunchbase 上查看更多信息